Overall Survival in Advanced Stage Mantle Cell Lymphoma after Early Autologous Stem Cell Transplantation with Cisplatin, Etoposide ,Cytarabine and Melphalan (PEAM) As a Conditioning Regimen

被引：0

作者：

Franco, Daniel ^{[1
]}

Tellez, Fernando ^{[1
]}

Solis-Armenta, Ruben ^{[1
]}

Leal Alanis, Araceli ^{[1
]}

Cruz Castillo, Carlos ^{[2
]}

Valero Saldana, Luis Manuel ^{[1
]}

Acosta Maldonado, Brenda Lizeth ^{[2
]}

机构：

[1] Inst Nacl Cancerol, Mexico City, DF, Mexico

[2] Inst Natl Cancerol, Dept Hematol, Mexico City, DF, Mexico

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-191183

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients [J].

Visani, Giuseppe ;

Malerba, Lara ;

Stefani, Pietro Maria ;

Capria, Saveria ;

Galieni, Piero ;

Gaudio, Francesco ;

Specchia, Giorgina ;

Meloni, Giovanna ;

Gherlinzoni, Filippo ;

Giardini, Claudio ;

Falcioni, Sadia ;

Cuberli, Francesca ;

Gobbi, Marco ;

Sarina, Barbara ;

Santoro, Armando ;

Ferrara, Felicetto ;

Rocchi, Marco ;

Ocio, Enrique M. ;

Dolores Caballero, Maria ;

Isidori, Alessandro .

BLOOD, 2011, 118 (12) :3419-3425

[42] Busilvex in combination with etoposide and melphalan as conditioning regimen in autologous haematopoietic cell transplantation for lymphomas: efficacy and safety [J].

Sakellari, I. ;

Mallouri, D. ;

Constantinou, V. ;

Baliakas, P. ;

Iskas, M. ;

Karypidis, K. ;

Apostolou, C. ;

Kaloyannidis, P. ;

Batsis, I. ;

Vadikoliou, C. ;

Papaemmanouil, S. ;

Palladas, P. ;

Smias, C. ;

Anagnostopoulos, A. .

BONE MARROW TRANSPLANTATION, 2012, 47 :S450-S450

[43] A Phase II Study Of V-BEAM (Bortezomib, Carmustine, Etoposide, Cytarabine, and Melphalan) As Conditioning Regimen Prior To Second Autologous Stem Cell Transplantation For Multiple Myeloma [J].

Wang, Tzu-Fei ;

Fiala, Mark A. ;

Wu, Ningying ;

Fletcher, Theresa ;

Abboud, Camille N. ;

Cashen, Amanda F. ;

Dipersio, John F. ;

Uy, Geoffrey L. ;

Westervelt, Peter ;

Stockerl-Goldstein, Keith E. ;

Vij, Ravi .

BLOOD, 2013, 122 (21)

[44] Prognostic Variables of Progression Free Survival in Mantle Cell Lymphoma after Autologous Stem Cell Transplantation [J].

Churnetski, Michael C. ;

Switchenko, Jeffrey M. ;

Goyal, Subir ;

Shanmugasundaram, Krithika ;

Calzada, Oscar ;

Kolla, Bhaskar ;

Bachanova, Veronika ;

Gerson, James N. ;

Barta, Stefan K. ;

Maldonado, Edward ;

Gordon, Max ;

Danilov, Alexey V. ;

Grover, Natalie S. ;

Mathews, Stephanie ;

Burkart, Madelyn ;

Karmali, Reem ;

Sawalha, Yazeed ;

Hill, Brian T. ;

Ghosh, Nilanjan ;

Park, Steven I. ;

Epperla, Narendranath ;

Bond, David ;

Badar, Talha ;

Blum, Kristie A. ;

Guo, Jin ;

Martin, Peter ;

Hamadani, Mehdi ;

Fenske, Timothy S. ;

Malecek, Mary ;

Kahl, Brad S. ;

Flowers, Christopher ;

Cohen, Jonathon B. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)

[45] TEAM (Thiotepa, Etoposide, Cytarabine, Melphalan) is an effective high-dose chemotherapy consolidation regimen with autologous stem cell transplantation for patients with relapsed lymphoma in complete remission [J].

Pester, F. ;

Klink, A. ;

Scholl, S. ;

Schilling, K. ;

Muegge, L. ;

Hoeffken, K. ;

Sayer, H. .

BONE MARROW TRANSPLANTATION, 2008, 41 :S252-S252

[46] Autologous stem cell transplantation and Rituximab independently prolong response duration in advanced stage mantle cell lymphoma [J].

Hoster, E. ;

Metzner, B. ;

Pfreundschuh, M. ;

Truemper, L. ;

Hallek, M. ;

Woermann, B. ;

Duehrsen, U. ;

Gisselbracht, C. ;

Kluin-Nelemans, J. C. ;

Van Hoof, A. ;

Unterhalt, M. ;

Hiddemann, W. ;

Dreyling, M. .

ONKOLOGIE, 2010, 33 :202-202

[47] TECAM (thiotepa, etoposide, cyclophosphamide, Ara-c and melphalan) as conditoning regimen for autologous stem cell transplantation in patients with lymphoma [J].

Patir, P. ;

Soyer, N. ;

Sahin, F. ;

Saydam, G. ;

Tobu, M. ;

Tombuloglu, M. ;

Vural, F. .

BONE MARROW TRANSPLANTATION, 2017, 52 :S336-S337

[48] Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma [J].

Kim, Ji-Won ;

Lee, Hyun Jung ;

Yi, Hyeon Gyu ;

Kim, Byung-Su ;

Bang, Soo-Mee ;

Kim, Jin Seok ;

Kim, Inho ;

Yoon, Sung-Soo ;

Lee, Jong Seok ;

Kim, Chul Soo ;

Park, Seonyang ;

Kim, Byoung Kook .

AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (05) :479-483

[49] Autologous Stem Cell Transplantation with Benda-Eam (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin's Lymphoma [J].

Noesslinger, Thomas ;

Panny, Michael ;

Moestl, Michaela ;

Koller, Elisabeth ;

Keil, Felix .

BLOOD, 2016, 128 (22)

[50] Autologous Stem Cell Transplantation with Benda-BEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin's Lymphoma [J].

Noesslinger, Thomas ;

Moestl, Michaela ;

Tinchon, Christoph ;

Koller, Elisabeth ;

Linkesch, Werner ;

Keil, Felix .

BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →